Open App
Company / Named in our posts

Albireo Pharma, Inc..

Follow Albireo Pharma, Inc.

A rare disease company developing novel bile acid modulators to treat pediatric and adult liver diseases.[1]

01Deal
01

Deals on Carrywatch

Every deal that names Albireo Pharma, Inc., and its role in each.

Sagard Healthcare Partners (Delaware) LP / Albireo Pharma, Inc. and Albireo AB

Sagard Healthcare Partners (Delaware) LP agrees to buy Albireo Pharma, Inc. and Albireo AB

See deal details
02

Deal Web

Albireo Pharma, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.

03

News

Loading headlines.

04

Sources

As of 24 Oct 2026.

  1. 01
    Exhibit 99.1

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

  2. 02
    Form 8-K

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming Albireo Pharma, Inc.:

  1. P01